SPINK4
gene geneOn this page
Also known as PEC-60MGC133107
Summary
SPINK4 (serine peptidase inhibitor Kazal type 4, HGNC:16646) is a protein-coding gene on chromosome 9p13.3, encoding Serine protease inhibitor Kazal-type 4 (O60575).
Predicted to enable serine-type endopeptidase inhibitor activity. Predicted to be located in extracellular region.
Source: NCBI Gene 27290 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 24 total
- MANE Select transcript:
NM_014471
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16646 |
| Approved symbol | SPINK4 |
| Name | serine peptidase inhibitor Kazal type 4 |
| Location | 9p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PEC-60, MGC133107 |
| Ensembl gene | ENSG00000122711 |
| Ensembl biotype | protein_coding |
| OMIM | 613929 |
| Entrez | 27290 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000379721, ENST00000379725
RefSeq mRNA: 1 — MANE Select: NM_014471
NM_014471
CCDS: CCDS6536
Canonical transcript exons
ENST00000379721 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000832777 | 33245112 | 33245152 |
| ENSE00000832778 | 33246616 | 33246728 |
| ENSE00001482272 | 33240167 | 33240269 |
| ENSE00001933837 | 33248426 | 33248567 |
Expression profiles
Bgee: expression breadth ubiquitous, 146 present calls, max score 99.68.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6042 / max 172.5546, expressed in 55 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 96439 | 0.6042 | 55 |
Top tissues by expression
282 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ileal mucosa | UBERON:0000331 | 99.68 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 98.05 | gold quality |
| rectum | UBERON:0001052 | 96.58 | gold quality |
| jejunal mucosa | UBERON:0000399 | 96.11 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 95.92 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 95.72 | gold quality |
| duodenum | UBERON:0002114 | 93.35 | gold quality |
| small intestine | UBERON:0002108 | 93.26 | gold quality |
| colonic mucosa | UBERON:0000317 | 93.05 | gold quality |
| vermiform appendix | UBERON:0001154 | 93.02 | gold quality |
| caecum | UBERON:0001153 | 91.54 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 91.53 | gold quality |
| pancreatic ductal cell | CL:0002079 | 83.61 | silver quality |
| transverse colon | UBERON:0001157 | 80.65 | gold quality |
| jejunum | UBERON:0002115 | 80.27 | gold quality |
| intestine | UBERON:0000160 | 76.67 | gold quality |
| diaphragm | UBERON:0001103 | 74.95 | gold quality |
| type B pancreatic cell | CL:0000169 | 74.30 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 73.54 | silver quality |
| smooth muscle tissue | UBERON:0001135 | 72.79 | gold quality |
| endometrium epithelium | UBERON:0004811 | 72.56 | gold quality |
| large intestine | UBERON:0000059 | 71.84 | gold quality |
| islet of Langerhans | UBERON:0000006 | 71.76 | gold quality |
| adrenal tissue | UBERON:0018303 | 70.83 | gold quality |
| colon | UBERON:0001155 | 70.74 | gold quality |
| olfactory bulb | UBERON:0002264 | 70.00 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 65.84 | silver quality |
| tongue squamous epithelium | UBERON:0006919 | 65.63 | gold quality |
| vastus lateralis | UBERON:0001379 | 65.27 | gold quality |
| colonic epithelium | UBERON:0000397 | 65.17 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-125970 | yes | 21583.90 |
| E-CURD-46 | yes | 12926.18 |
| E-MTAB-8410 | yes | 5950.84 |
| E-MTAB-7316 | yes | 40.92 |
| E-ANND-3 | no | 2.38 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): SPDEF
Literature-anchored findings (GeneRIF, showing 2)
- this study shows that downregulated SPINK4 is associated with poor survival in colorectal cancer (PMID:31888570)
- SPINK4 modulates inhibition of glycolysis against colorectal cancer progression. (PMID:38747892)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | spink4 | ENSDARG00000091609 |
| mus_musculus | Spink4 | ENSMUSG00000028415 |
| rattus_norvegicus | Spink4 | ENSRNOG00000008252 |
Protein
Protein identifiers
Serine protease inhibitor Kazal-type 4 — O60575 (reviewed: O60575)
Alternative names: Peptide PEC-60 homolog
All UniProt accessions (3): O60575, Q5VZE7, V9HWG8
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
RefSeq proteins (1): NP_055286* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002350 | Kazal_dom | Domain |
| IPR036058 | Kazal_dom_sf | Homologous_superfamily |
| IPR039932 | Spink4-like | Family |
Pfam: PF00050
UniProt features (8 total): disulfide bond 3, signal peptide 1, chain 1, domain 1, site 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O60575-F1 | 84.92 | 0.48 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 48–49 (reactive bond)
Disulfide bonds (3): 37–68, 46–65, 54–86
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 0 (showing top):
GO Biological Process (1): response to xenobiotic stimulus (GO:0009410)
GO Molecular Function (3): serine-type endopeptidase inhibitor activity (GO:0004867), protein binding (GO:0005515), peptidase inhibitor activity (GO:0030414)
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| response to chemical | 1 |
| serine-type endopeptidase activity | 1 |
| endopeptidase inhibitor activity | 1 |
| binding | 1 |
| enzyme inhibitor activity | 1 |
| peptidase activity | 1 |
| peptidase regulator activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
612 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPINK4 | REG4 | Q9BYZ8 | 532 |
| SPINK4 | TFF3 | Q07654 | 512 |
| SPINK4 | SPDEF | O95238 | 499 |
| SPINK4 | SPINK13 | Q1W4C9 | 492 |
| SPINK4 | SPINK6 | Q6UWN8 | 483 |
| SPINK4 | ITLN1 | Q8WWA0 | 467 |
| SPINK4 | AGR2 | O95994 | 460 |
| SPINK4 | SPINK5 | Q9NQ38 | 452 |
| SPINK4 | SPINK9 | Q5DT21 | 446 |
| SPINK4 | SPINK14 | Q6IE38 | 442 |
| SPINK4 | D6RI10 | D6RI10 | 437 |
| SPINK4 | CLCA1 | A8K7I4 | 431 |
| SPINK4 | SPINK1 | P00995 | 410 |
| SPINK4 | SPINK7 | P58062 | 389 |
| SPINK4 | ZG16 | O60844 | 378 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SPINK4 | SGTB | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPINK4 | PLXNA2 | psi-mi:“MI:0914”(association) | 0.530 |
| FXYD1 | SPINK4 | psi-mi:“MI:0914”(association) | 0.350 |
| SPINK4 | SGTB | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (18): LAMA3 (Affinity Capture-MS), HTRA1 (Affinity Capture-MS), MINPP1 (Affinity Capture-MS), MICA (Affinity Capture-MS), PLXNA2 (Affinity Capture-MS), SPPL2B (Affinity Capture-MS), CERCAM (Affinity Capture-MS), TMEM67 (Affinity Capture-MS), SGTB (Two-hybrid), CERCAM (Affinity Capture-MS), MINPP1 (Affinity Capture-MS), DCAF10 (Affinity Capture-MS), PLXNA2 (Affinity Capture-MS), SPPL2B (Affinity Capture-MS), TMEM67 (Affinity Capture-MS)
ESM2 similar proteins: A0A1Q1NL17, A0A3G5BID2, B4QW11, D0MVC9, D3GGZ8, K7WMX6, L0GB04, O55159, O60575, O97176, P00995, P00996, P01005, P09036, P09655, P09656, P0DKM7, P0DPZ9, P0DQC4, P0DQC5, P0DQC9, P0DQD0, P0DQG2, P0DQV2, P0DRJ1, P0DXW5, P0DXX0, P16422, P20155, P26461, P37109, P41998, P81481, Q09553, Q09TK7, Q177W0, Q1WER1, Q3T0L5, Q5DT21, Q5MGC9
Diamond homologs: A2ASQ1, A5YT95, G4V4G1, O00468, O35679, O60575, O62650, O93390, O95633, P07214, P09486, P0DKM8, P0DKT1, P10184, P10669, P13213, P16895, P16975, P19883, P20112, P21674, P23499, P25304, P31514, P31515, P31696, P36233, P36377, P36378, P37109, P47931, P50291, Q12841, Q14515, Q1LZB9, Q58D84, Q5R767, Q5R9Y1, Q62356, Q62632
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 22 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
454 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:33245110:A:AG | acceptor_gain | 1.0000 |
| 9:33245111:G:GG | acceptor_gain | 1.0000 |
| 9:33245111:GAA:G | acceptor_gain | 1.0000 |
| 9:33246725:GGAT:G | donor_gain | 1.0000 |
| 9:33246726:GAT:G | donor_gain | 1.0000 |
| 9:33246726:GATG:G | donor_gain | 1.0000 |
| 9:33246729:G:GG | donor_gain | 1.0000 |
| 9:33240267:GGG:G | donor_gain | 0.9900 |
| 9:33240268:GGG:G | donor_gain | 0.9900 |
| 9:33245105:GTTTC:G | acceptor_loss | 0.9900 |
| 9:33245106:TTTCA:T | acceptor_loss | 0.9900 |
| 9:33245107:TTCA:T | acceptor_loss | 0.9900 |
| 9:33245108:TCA:T | acceptor_loss | 0.9900 |
| 9:33245109:CA:C | acceptor_loss | 0.9900 |
| 9:33245110:AGA:A | acceptor_loss | 0.9900 |
| 9:33245111:G:GA | acceptor_loss | 0.9900 |
| 9:33245111:GA:G | acceptor_gain | 0.9900 |
| 9:33245148:GAATG:G | donor_gain | 0.9900 |
| 9:33246613:C:G | acceptor_gain | 0.9900 |
| 9:33246614:A:AG | acceptor_gain | 0.9900 |
| 9:33246615:G:GG | acceptor_gain | 0.9900 |
| 9:33246615:GCC:G | acceptor_gain | 0.9900 |
| 9:33246615:GCCC:G | acceptor_gain | 0.9900 |
| 9:33246615:GCCCA:G | acceptor_gain | 0.9900 |
| 9:33246728:TGT:T | donor_loss | 0.9900 |
| 9:33246729:G:GA | donor_loss | 0.9900 |
| 9:33246730:T:TC | donor_loss | 0.9900 |
| 9:33248421:CCTA:C | acceptor_loss | 0.9900 |
| 9:33248422:CTA:C | acceptor_loss | 0.9900 |
| 9:33248423:TAGA:T | acceptor_loss | 0.9900 |
AlphaMissense
559 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:33248466:T:A | C86S | 0.984 |
| 9:33248467:G:C | C86S | 0.984 |
| 9:33246673:T:A | C54S | 0.982 |
| 9:33246674:G:C | C54S | 0.982 |
| 9:33248466:T:C | C86R | 0.979 |
| 9:33246715:T:A | C68S | 0.977 |
| 9:33246716:G:C | C68S | 0.977 |
| 9:33246715:T:C | C68R | 0.975 |
| 9:33248468:C:G | C86W | 0.974 |
| 9:33246622:T:A | C37S | 0.971 |
| 9:33246623:G:C | C37S | 0.971 |
| 9:33246725:G:C | R71P | 0.970 |
| 9:33246717:C:G | C68W | 0.969 |
| 9:33246713:T:C | L67P | 0.967 |
| 9:33246673:T:C | C54R | 0.964 |
| 9:33246623:G:A | C37Y | 0.963 |
| 9:33246677:G:A | G55D | 0.962 |
| 9:33246706:T:A | C65S | 0.962 |
| 9:33246707:G:C | C65S | 0.962 |
| 9:33246716:G:A | C68Y | 0.958 |
| 9:33246675:C:G | C54W | 0.955 |
| 9:33246695:A:G | Y61C | 0.955 |
| 9:33246622:T:C | C37R | 0.950 |
| 9:33246682:G:C | D57H | 0.950 |
| 9:33246673:T:G | C54G | 0.949 |
| 9:33246674:G:A | C54Y | 0.949 |
| 9:33246682:G:T | D57Y | 0.946 |
| 9:33246676:G:T | G55C | 0.945 |
| 9:33246624:T:G | C37W | 0.944 |
| 9:33246617:C:A | P35H | 0.943 |
dbSNP variants (sampled 300 via entrez): RS1000085858 (9:33245454 T>C,G), RS1000494958 (9:33243597 C>T), RS1000645423 (9:33238590 A>T), RS1000905796 (9:33238770 C>G), RS1001580543 (9:33241276 C>A,T), RS1002326591 (9:33239753 C>T), RS1002478261 (9:33245615 C>A), RS1002582026 (9:33245300 T>C,G), RS1002858901 (9:33244117 C>A,T), RS1002992611 (9:33242159 T>C), RS1003081401 (9:33241298 A>G), RS1003143844 (9:33248576 G>A), RS1003250723 (9:33248235 G>A), RS1003255533 (9:33248853 A>G), RS1003449687 (9:33242816 C>T)
Disease associations
OMIM: gene MIM:613929 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003123_21 | Severe influenza A (H1N1) infection | 9.000000e-11 |
| GCST003124_25 | Mild influenza (H1N1) infection | 1.000000e-13 |
| GCST003125_4 | Influenza A (H1N1) infection | 1.000000e-14 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:1001488 | influenza A (H1N1) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| propionaldehyde | increases methylation | 1 |
| bisphenol A | decreases expression | 1 |
| nonanal | increases methylation | 1 |
| n-hexanal | increases methylation | 1 |
| butyraldehyde | increases methylation | 1 |
| caprylic aldehyde | increases methylation | 1 |
| hydroquinone | decreases expression | 1 |
| pentanal | increases methylation | 1 |
| heptanal | increases methylation | 1 |
| Estradiol | increases expression | 1 |
| Fluorouracil | affects expression | 1 |
| Malathion | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Zinc | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.